(S)-1,2,3,4-Tetrahydro-1-Naphthoic Acid CAS 85977-52-2 Purity ≥99.0% e.e.≥99.0% Palonosetron Hydrochloride Intermediate Factory
Commercial Supply Palonosetron Hydrochloride and Related Intermediates:
(S)-1,2,3,4-Tetrahydro-1-Naphthoic Acid CAS: 85977-52-2
(R)-1,2,3,4-Tetrahedro-1-Naphthoic Acid CAS: 23357-47-3
(S)-3-Aminoquinuclidine Dihydrochloride CAS: 119904-90-4
3-Quinuclidinone Hydrochloride CAS: 1193-65-3
1-Naphthoic Acid CAS: 86-55-5
Palonosetron Hydrochloride CAS: 135729-62-3 API
Chemical Name | (S)-1,2,3,4-Tetrahydro-1-Naphthoic Acid |
Synonyms | (1S)-1,2,3,4-Tetrahydronaphthalene-1-Carboxylic acid |
CAS Number | 85977-52-2 |
CAT Number | RF-CC111 |
Stock Status | In Stock, Production Scale Up to Tons |
Molecular Formula | C11H12O2 |
Molecular Weight | 176.21 |
Density | 1.186g/cm3 |
Melting Point | 54.0~56.0℃ |
Boiling Point | 342.7°C at 760 mmHg |
Refractive Index | 1.576 |
Brand | Ruifu Chemical |
Item | Specifications |
Appearance | White or Almost White Crystalline Powder |
Chemical Purity | ≥99.0% |
Enantimoer Excess | e.e. ≥99.0% |
Isomer Impurity | ≤1.0% |
Loss on Drying | ≤0.50% |
Relate Substance | ≤1.0% |
Moisture (K.F) | ≤1.0% |
Specific Rotation [α]D20 | -59.0°~ -63.0°(C=0.3 in Benzence) |
Heavy Metals | ≤20ppm |
Storage | 5-8℃ Airtightness |
Test Standard | Enterprise Standard |
Usage | Palonosetron Hydrochloride (CAS: 135729-62-3) Intermediates |
(S)-1,2,3,4-tetrahydro-1-Naphthoic Acid CAS: 85977-52-2 Route of Synthesis
Package: Bottle, Cardboard Drum, 25kg/Drum, or according to customer's requirement.
Storage Condition: Store in sealed containers at cool and dry place; Protect from light, moisture and pest infestation.
Shanghai Ruifu Chemical Co., Ltd. is the leading manufacturer and supplier of (S)-1,2,3,4-Tetrahydro-1-Naphthoic Acid (CAS: 85977-52-2) with high quality. It is an intermediate typically in the synthesis of Palonosetron Hydrochloride (CAS: 135729-62-3).
Palonosetron Hydrochloride (CAS: 135729-62-3) is a novel 5-HT3 receptor antagonist launched as an injectable agent for the prevention of acute and delayed nausea and vomiting associated with cancer chemotherapy. It has a much longer half-life (~40 h) than the other currently available 5-HT3 antagonists, which provides efficacy advantages in the prevention of delayed nausea and vomiting that typically occurs after 24 h and up to six days post chemotherapy administration. With 1,2,3,4-tetrahydro-1-Naphthoic Acid as the starting material, the split, amination, reduction, cyclization, salt of palonosetron hydrochloride granisetron.